EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitOpen access

Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation

B Trijzelaar

Biotherapy · 1993

DOI: 10.1007/bf01877422 ↗

At a glance

Übersichtsarbeit in Biotherapy, 1993. Written by B Trijzelaar. Institution: Strategic Biotech International, Zeist, The Netherlands. Cited 11 times so far (Crossref). The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Subjects

MeSH terms (MEDLINE)

AnimalsBiotechnologyEuropean UnionGuidelines as TopicHumansQuality ControlReproducibility of ResultsViruses

Authors and institutions

  • Strategic Biotech International, Zeist, The Netherlands.

Cite

APA

Trijzelaar, B. (1993). Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation. Biotherapy. https://doi.org/10.1007/bf01877422

Vancouver

Trijzelaar B. Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation. Biotherapy. 1993. doi:10.1007/bf01877422

BibTeX
@article{Trijzelaar1993,
  author = {Trijzelaar, B},
  title = {Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation},
  journal = {Biotherapy},
  year = {1993},
  doi = {10.1007/bf01877422}
}
Start for free →